Planet 13 Holdings (PLNH) Income from Continuing Operations (2021 - 2026)
Planet 13 Holdings (PLNH) reported Income from Continuing Operations of 8095802.0 for Q1 2026, down 295.46% year-over-year from 4141844.62 in Q1 2025, and down 232.19% quarter-over-quarter from 6124165.0 in Q4 2025.
Planet 13 Holdings (PLNH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Income from Continuing Operations data on file, last reported at 8095802.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 8095802.0, down 295.46% year-over-year; the trailing twelve-month figure through Mar 2026 was 59228732.0 (down 35.53% YoY), and the FY2025 annual result was 53180097.0, down 11.26% from the prior year.
- Income from Continuing Operations slipped to 8095802.0 in Q1 2026 per PLNH's latest filing, from 6124165.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 6124165.0 in Q4 2025 and troughed at 46290701.0 in Q3 2023.
- A 5-year average of 13042661.82 and a median of 7141476.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 2131.73% in 2022, then jumped 123.16% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 33339690.0 in 2022, then soared by 91.86% to 2714573.0 in 2023, then plunged by 873.96% to 26438751.0 in 2024, then jumped by 123.16% to 6124165.0 in 2025, then slumped by 232.19% to 8095802.0 in 2026.
- Business Quant data shows PLNH's Income from Continuing Operations at 8095802.0 in Q1 2026, 6124165.0 in Q4 2025, and 43955853.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | -8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | -43.96 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | -26.44 Mn |
| Sep 30, 2024 | -7.14 Mn |
| Jun 30, 2024 | -8.07 Mn |
| Mar 31, 2024 | -5.87 Mn |
| Dec 31, 2023 | -2.71 Mn |
| Sep 30, 2023 | -46.29 Mn |
| Jun 30, 2023 | -4.62 Mn |
| Mar 31, 2023 | -8.48 Mn |
| Dec 31, 2022 | -33.34 Mn |
| Sep 30, 2022 | -6.34 Mn |
| Jun 30, 2022 | -7.07 Mn |
| Mar 31, 2022 | -4.07 Mn |
| Dec 31, 2021 | -27.41 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | 347,962.00 |